Publication date: Available online 30 November 2018
Source: Archives of Oral Biology
Author(s): Takuya Higuchi, Nao Suzuki, Seigo Nakaya, Sami Omagari, Masahiro Yoneda, Takashi Hanioka, Takao Hirofuji
Abstract
Objective
To evaluate the combined use ofLactobacillus salivarius WB21 and (–)-epigallocatechin gallate (EGCg) for oral health maintenance.
Design
The effects ofL. salivarius WB21 on growth of Streptococcus mutans, the insoluble glucan produced by S. mutans, and on growth of Porphyromonas gingivalis were evaluated in vitro. In addition, the susceptibility of five oral pathogenic bacteria and L. salivarius WB21 to EGCg, the inhibiting effect of EGCg on methyl mercaptan, and the effects of L. salivarius WB21 and EGCg in combination on growth of P. gingivalis were examined.
Results
Lactobacillus salivarius WB21 showed concentration-dependent inhibition of the growth of S. mutans. Addition of L. salivarius WB21 inhibited production of the insoluble glucan by S. mutans (p < 0.001). A filtrate of L. salivarius WB21 culture solution inhibited growth of P. gingivalis (p < 0.001 vs. control), and this effect was enhanced when it was used in combination with EGCg (p < 0.001 vs. the addition of L. salivarius WB21). In addition, EGCg directly inhibited methyl mercaptan in a concentration-dependent manner (p < 0.001). Concerning bacterial susceptibility to EGCg, growth of P. gingivalis, Prevotella intermedia, and Fusobacterium nucleatum was inhibited at 2.5 mg/mL of EGCg, while that of L. salivarius WB21 was inhibited at 25 mg/mL EGCg.
Conclusions
Our results imply thatL. salivarius WB21 may be useful for controlling dental caries, periodontitis, and oral malodor. In addition, the effects of L. salivarius WB21 on periodontitis and oral malodor may be synergistically enhanced by use in combination with EGCg.
from OroFacial via a.sfakia on Inoreader https://ift.tt/2E8wtkq
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.